Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Long-Term Debt of $431.1 thousand for fiscal year 2023.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2023 | $431.1K | +4.1% |
| 2022 | $414.0K | — |
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed an increase of +4.1% in Long-Term Debt compared to the prior fiscal year.
- Over the 2022–2023 period, Cordyceps Sunshine Biotech Holdings Co., Ltd.’s long-term debt has grown by 4.1% (from $414.0 thousand to $431.1 thousand).
- The most recent figure is from Cordyceps Sunshine Biotech Holdings Co., Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on June 13, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: